Genetic biomarkers steer progress in ALS: Amyotrophic lateral sclerosis (ALS) remains a mystery to researchers and the physicians tasked to treat the disease. Once diagnosed, ALS patients struggle to stay alive for five years. After the first symptoms appear, ALS progresses to quadriplegia and respiratory insufficiency within a few years.